The association of isoconazole–diflucortolone in the treatment of pediatric tinea corporis

Stefano Veraldi, Rossana Schianchi, Paolo Pontini, Alberto Gorani

Research output: Contribution to journalArticlepeer-review


Background: Tinea corporis is a common mycotic infection in children. Staphylococcus aureus superinfections may be observed in atopic children with tinea corporis suffering from severe pruritus and consequent scratching. Objective: From 2006 to 2011, we observed 288 children with mycologically proven tinea corporis. In 39 of them (13.5%) tinea corporis was superinfected by S. aureus: all these children were affected by atopic dermatitis. We interpreted these bacterial superinfections as the clinical result of scratching due to pruritus. Methods: In 2012, we decided to treat all children with a single lesion of tinea corporis with a combination of 1% isoconazole nitrate and 0.1% diflucortolone valerate cream (one application/day for 5–7 days), followed by a treatment with isoconazole or clotrimazole or ciclopirox cream (two applications/day for two weeks). Results: From 2012 to 2014, we observed 108 children with tinea corporis confirmed by mycological examinations. Clinical and mycological recovery was observed in 93 of them (86.1%). Only four of these children (3.7%) developed S. aureus superinfections. Conclusions: Our study in atopic children with tinea corporis superinfected by S. aureus confirms that a topical therapy with the association isoconazole–diflucortolone is useful and safe.

Original languageEnglish
Pages (from-to)200-201
Number of pages2
JournalJournal of Dermatological Treatment
Issue number2
Publication statusPublished - 2018


  • Atopic dermatitis
  • children
  • diflucortolone valerate
  • isoconazole nitrate
  • Staphylococcus aureus
  • tinea corporis

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'The association of isoconazole–diflucortolone in the treatment of pediatric tinea corporis'. Together they form a unique fingerprint.

Cite this